Recently, KOFA Biologics successfully passed the verification plan of serum biochemical index detection capability organized by the China Institute of Food and Drug Control (hereinafter referred to as the "CCDI").

This is the third year that KOFA Biological participated in the inspection index detection ability verification activities held by the CCDI, and participated in all the projects of "NIFDC-PT-509 Serum Biochemical Index detection ability Verification Plan", including: ALT, AST, ALP, GGT, CK, LDH, TBIL, UREA, CRE, GLU, TC, TG, TP, ALB, Cl-, K+, Na+ all passed with full marks!

SCCL interventricular quality assessment results   

Shanghai Clinical Laboratory Center (SCCL) announced the results of the second ventricular quality evaluation in 2024. KOFA biological D-Dimer, GR, ApoE and other projects have passed the evaluation with full marks.

The NIFDC-PT-509 "Capability Verification Program for Detection of Biochemical Indicators in Serum" is organized, coordinated and implemented by the China Institute for Food and Drug Control and operates the capability verification program in accordance with the requirements of CNAS-CL03:2010 "Accreditation Criteria for Capability Verification Providers". Competence verification plan is an important method of inter-laboratory quality control to monitor the quality of laboratory tests. By analyzing the results of capability verification and taking corrective measures to the unsatisfactory results, the level of laboratory testing can be promoted and improved.

In this evaluation, KOFA Biology has been recognized by the official authority with its excellent technical strength and strict quality control system. Kofang will continue to strengthen quality management, strictly abide by laboratory management norms, improve the standardization and traceability of testing items, ensure that more accurate and efficient testing services are provided to clinicians and patients, jointly promote the healthy development of the industry, and make greater contributions to the development of the medical industry.